ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT03480646 · COMPLETED
Trial details
- NCT number
- NCT03480646
- Sponsor
- Constellation Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2021-02-03
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.